Biotech

Biofuel Feedstocks Latest Candidate: Kudzu

Treehugger | Posted 06.26.2008 | Green


yes, all of those vines are kudzu. photo via flickr Our colleagues over at Discovery News have brought attention to a new report that an invasive ...

Breaking out of the 'academic comfort zone' for higher returns on medical research philanthropy

Katie Hood | Posted 06.26.2008 | Living


Katie Hood

Last week I spoke on a couple of panels at the BIO Global Convention in San Diego. At one point I found myself seated next to Joshua Boger, the CEO of...

Corn Utensils Useless Without Major Composting Efforts

Los Angeles Times | Jenn Garbee | Posted 06.18.2008 | Green


Now that you feel environmentally conscientious for having used a corn fork -- those forks made with corn starch that lately are the darlings of the t...

Scientists Clone Cancer-Sniffing Dog: Pets Are Next

Huffington Post | Posted 06.16.2008 | Home


In South Korea, scientists have been cloning animals with desirable traits and genetic alterations. Last year, researchers cloned cats that glow under...

$200 a Barrel Oil: It Could Go Much Higher!

Vivian Norris de Montaigu | Posted 05.07.2008 | Business


Vivian Norris de Montaigu

Oil power and money is in the hands of people and governments I would not want to eat dinner with, much less ask to make important decisions affecting the future of the planet. Pay attention.

Shortage Weakens Resistance To Biotech Crops

New York Times | Andrew Pollack | Posted 04.21.2008 | Business


Soaring food prices and global grain shortages are bringing new pressures on governments, food companies and consumers to relax their longstanding res...

Heads Monsanto Wins, Tails We Lose; The Genetically Modified Food Gamble

Robert Weissman | Posted 03.18.2008 | Business


Robert Weissman

There have been few experiments as reckless, overhyped and with as little potential upside as the rapid rollout of genetically modified crops. Last m...

Genzyme Drops $325 Million On Cholesterol Shot

Wall Street Journal | DAVID ARMSTRONG | Posted 01.08.2008 | Business


Genzyme Corp. said it would spend $325 million up front in a licensing and investment pact with Isis Pharmaceuticals Inc., securing partial rights to ...


 

 Site  Web ask.com